PLA2G12AP1: A Drug Target / Disease Biomarker (G100420258)

Target Name: PLA2G12AP1

NCBI ID: G100420258

PLA2G12AP1

Other Name(s): phospholipase A2 group XIIA pseudogene 1 | Phospholipase A2 group XIIA pseudogene 1

PLA2G12AP1: A Drug Target / Disease Biomarker

PLA2G12AP1 is a protein that is expressed in the endoplasmic reticulum (ER) and is involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. It is a member of the PLA2 family of proteins, which are known for their role in cell-cell adhesion and signaling.

PLA2G12AP1 has been identified as a potential drug target due to its involvement in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is also known as a biomarker for several diseases, including pancreatic cancer and colorectal cancer.

One of the key functions of PLA2G12AP1 is its role in cell adhesion. This protein helps to regulate the stickiness of cells to the surface of other cells, which is important for the development and progression of cancer. PLA2G12AP1 has been shown to play a role in the development of several types of cancer, including breast, ovarian, and prostate cancer.

In addition to its role in cell adhesion, PLA2G12AP1 is also involved in the regulation of cellular signaling pathways. This protein has been shown to play a role in several signaling pathways, including the TGF-β pathway and the NF-kappa-B pathway. These pathways are important for the development and progression of cancer, and PLA2G12AP1 has been shown to play a negative role in their regulation.

PLA2G12AP1 has also been shown to be involved in the regulation of cellular migration and invasion. This protein helps to regulate the movement of cells through the cytosm, which is important for the development and progression of cancer. PLA2G12AP1 has been shown to play a role in the regulation of the invasive properties of cancer cells.

In conclusion, PLA2G12AP1 is a protein that is involved in several cellular processes that are important for the development and progression of cancer. As a potential drug target, PLA2G12AP1 has the potential to be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition to its potential therapeutic uses, PLA2G12AP1 also has the potential as a biomarker for several diseases, including cancer. Further research is needed to fully understand the role of PLA2G12AP1 in these processes and to develop effective treatments for these diseases.

Protein Name: Phospholipase A2 Group XIIA Pseudogene 1

The "PLA2G12AP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLA2G12AP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets